The FDA recently approved a new device from Medtronic that turns a smartphone into a patient’s pacemaker monitor that can send stats to their doctor in real time. The MyCareLink Smart Monitor is able ...
On February 20, 2024, Medtronic MDT Corporation (NYSE: MDT, $85.90, Market Capitalization: $114.2 billion) in its 3Q24 earnings call announced that it no longer plans to spin-off its Patient ...
Medtronic has announced the commercial availability of the new Reveal® XT subcutaneous cardiac monitor in the United States. Designed to hep diagnose heart arrhythmias, the device communicates ...
Medtronic PLC has received government approval to sell an improved implantable heart monitor that wirelessly reads and transmits patient data to detect problems and help pinpoint causes of unexplained ...
Abbott Laboratories is linking its continuous glucose monitoring with automated insulin delivery by entering a global partnership with health tech giant Medtronic. The pairing of Abbott's leading ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback